TLS-inducing HSV oncolytic virus therapy (Candel Therapeutics/University of Birmingham)
N/A
Report date: 2025/06/11 10:35:27
Base Information
Drug NameTLS-inducing HSV oncolytic virus therapy (Candel Therapeutics/University of Birmingham)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Birmingham
China Registration ClassN/A
Develop Information
Active CompaniesCandel Therapeutics IncUniversity Of Birmingham
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A